We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$794M
Cap. Flow
+$588M
Cap. Flow %
3.81%
Top 10 Hldgs %
11.65%
Holding
3,018
New
218
Increased
954
Reduced
767
Closed
228

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$67.6M
2
SBUX icon
Starbucks
SBUX
+$63.1M
3
HLT icon
Hilton Worldwide
HLT
+$44.5M
4
META icon
Meta Platforms (Facebook)
META
+$44.3M
5
HOG icon
Harley-Davidson
HOG
+$43.2M

Sector Composition

Rank Sector Weight
1 Technology 15.53%
2 Healthcare 14.16%
3 Financials 11.14%
4 Industrials 10.83%
5 Consumer Discretionary 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
51
IBM
IBM
$202B
$66.1M 0.43%
456,402
-50,493
-10% -$6.45M
CVS icon
52
CVS Health
CVS
$137B
$65.7M 0.43%
633,754
-148,935
-19% -$14.5M
LLY icon
53
Eli Lilly
LLY
$1.07T
$65.3M 0.42%
907,284
+30,962
+4% +$2.34M
WAT icon
54
Waters Corp
WAT
$36.8B
$62.9M 0.41%
477,024
+66,432
+16% +$8.29M
AVY icon
55
Avery Dennison
AVY
$12.3B
$62.9M 0.41%
871,613
+67,526
+8% +$4.37M
NTAP icon
56
NetApp
NTAP
$32.9B
$61.5M 0.4%
2,255,070
+257,314
+13% +$6.23M
RTX icon
57
RTX Corp
RTX
$287B
$58.9M 0.38%
934,715
+50,467
+6% +$2.93M
USB icon
58
US Bancorp
USB
$99.6B
$58M 0.38%
1,430,056
+7,286
+0.5% +$291K
TMO icon
59
Thermo Fisher Scientific
TMO
$211B
$57.6M 0.37%
406,564
-82,316
-17% -$11M
CL icon
60
Colgate-Palmolive
CL
$72.6B
$57.2M 0.37%
809,496
-7,203
-0.9% -$479K
AMAT icon
61
Applied Materials
AMAT
$426B
$57.1M 0.37%
2,695,652
+1,677,611
+165% +$30.6M
ESRX
62
DELISTED
Express Scripts Holding Company
ESRX
$57M 0.37%
830,275
+555,805
+203% +$40M
LUV icon
63
Southwest Airlines
LUV
$22.1B
$56.9M 0.37%
1,270,537
+730,317
+135% +$29.7M
ADP icon
64
Automatic Data Processing
ADP
$100B
$55.3M 0.36%
616,299
-244,713
-28% -$20.5M
FL
65
DELISTED
Foot Locker
FL
$54.7M 0.35%
848,292
+79,601
+10% +$5.17M
META icon
66
Meta Platforms (Facebook)
META
$1.51T
$54.1M 0.35%
474,515
+420,241
+774% +$44.3M
IPG
67
DELISTED
Interpublic Group of Companies
IPG
$53.8M 0.35%
2,342,286
+181,854
+8% +$3.93M
CELG
68
DELISTED
Celgene Corp
CELG
$53.6M 0.35%
535,786
-4,298
-0.8% -$443K
HOG icon
69
Harley-Davidson
HOG
$2.68B
$53.6M 0.35%
1,044,512
+990,253
+1,825% +$43.2M
T icon
70
AT&T
T
$165B
$53.5M 0.35%
1,808,648
-832,175
-32% -$23M
SWKS icon
71
Skyworks Solutions
SWKS
$9.06B
$53.4M 0.35%
685,149
-180,218
-21% -$12.2M
MCD icon
72
McDonald's
MCD
$188B
$52.7M 0.34%
419,583
+119,410
+40% +$14.3M
VIG icon
73
Vanguard Dividend Appreciation ETF
VIG
$111B
$52.5M 0.34%
645,558
-37,291
-5% -$2.86M
TGT icon
74
Target
TGT
$62.1B
$51.9M 0.34%
631,212
+271,970
+76% +$20.5M
HLT icon
75
Hilton Worldwide
HLT
$74B
$51.7M 0.33%
764,725
+749,241
+4,839% +$44.5M

Similar funds

Glenmede Trust's Q1 2016 Portfolio in Review

As of Q1 2016, Glenmede Trust held 3,018 positions worth $15.4B, up 5.4% from $14.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust deployed $588M of net new capital in Q1 2016, opening 218 new positions and adding to 954 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 723,506 shares worth $26M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $50.7M trimmed.

  • Glenmede Trust's largest Q1 2016 buy was Vanguard FTSE Developed Markets ETF: 723,506 shares worth $26M.
  • Glenmede Trust added most to Oracle in Q1 2016, an estimated $67.6M increase.
  • Glenmede Trust's biggest Q1 2016 reduction was Activision Blizzard, cutting an estimated $50.7M.
  • Glenmede Trust fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $50M.
  • Glenmede Trust's ten largest holdings make up 12% of its $15.4B portfolio in Q1 2016.
  • Glenmede Trust opened 218 new positions and closed 228 in Q1 2016.
  • Glenmede Trust's portfolio value rose 5.4% quarter-over-quarter to $15.4B.

Based on Glenmede Trust's 13F filing for Q1 2016, filed 26 Apr 2016.